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Background
The D2 dopamine receptor (D2DR) and the Neurokinin A
receptor (NK2R) are G-protein-coupled receptors
(GPCRs). The first one is a major target of antipsychotics
and Parkinson's disease drugs while the second is
involved in smooth muscle contractions. GPCRs, also
known as seven transmembrane receptors (7TMRs), rep-
resent by far the largest family of plasma membrane recep-
tors, comprising approximately 1000 members in the
human genome. They regulate virtually all known physi-
ological processes in mammals including the senses of
smell, taste and vision. Indicative of their central impor-
tance in current clinical therapeutics is the very large
number of drugs that target these receptors, either directly
or indirectly. Although much progress has been made in
the pharmacological characterization of a large number of
GPCRs, the only three-dimensional structure available is
that of bovine rhodopsin. A 3D-structure of D2DR or
NK2R would increase our understanding of its molecular
mechanism and of the signal transduction of all GPCRs.
Results
In order to produce the large and homogenous receptor
preparations required for structural studies, heterologous
production procedures have been established using the
methylotrophic yeast Pichia pastoris (D2DR) and SFV-
infected mammalian cell lines (NK2R). The receptors,
produced as a fusion protein with both a Flag-tag and a
His10 tag at their Nterminus and a biotinylation domain at
their C-terminus for immuno-detection and purification,
shows specific binding activity with their selective antago-
nists (Spiperone for D2DR and SR48,968 for NK2R). Pre-
liminary purification procedures in a scalable fashion
were designed using a mixture of sugarbased detergents,
Cholesteryl-HemiSuccinate and other lipids (POPC,
POPE, POPG).
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